Empagliflozin does not improve contractile reserve in heart failure: Data from Empire HF trial - Medical Dialogues
6/14/2022 12:00:00 AM2 years 10 months ago
by Medha Baranwal
by Medha Baranwal
Denmark: The addition of SGLT2 inhibitor empagliflozin to guideline-directed HF therapy for 12 weeks ...
Denmark: The addition of SGLT2 inhibitor empagliflozin to guideline-directed HF therapy for 12 weeks did not improve left ventricular (LV) contractile reserve in patients with heart failure (HF) and … [+2483 chars]
full article...